Biotech Firm 180 Life Sciences Rebrands as ETHZilla, Invests $425M in Ethereum Amid Strategic Shift

July 29, 2025
Biotech Firm 180 Life Sciences Rebrands as ETHZilla, Invests $425M in Ethereum Amid Strategic Shift
  • 180 Life Sciences Corp., now rebranded as ETHZilla, is shifting its focus from biotechnology to cryptocurrency with a substantial investment in Ethereum, establishing a $425 million treasury through a private investment in public equity (PIPE).

  • Originally founded in 2016 as a clinical-stage biotech firm, 180 Life Sciences went public in 2020 but has seen its stock plummet over 99.9%, currently trading under $3.00 with a market cap around $17 million.

  • The company plans to concentrate its resources on Ether, marking a significant departure from its previous business model, while maintaining its current management and board for continuity.

  • This pivot raises regulatory and investor concerns, particularly given the increased scrutiny from the U.S. Securities and Exchange Commission regarding corporate involvement in cryptocurrencies.

  • The decision to invest in Ethereum reflects a strategic response to economic uncertainties and signals the growing role of digital assets in institutional portfolios.

  • The funds raised will primarily be used to purchase Ethereum, with Electric Capital managing the Ether treasury and overseeing yield generation from various on-chain activities.

  • While there is institutional support for the transition, concerns remain about the sustainability of the company's stock valuation at $3.36 per share and its overall market cap.

  • The firm faces inherent risks associated with this strategy, including Ethereum's price volatility and potential distractions from its core biotech research and development.

  • This investment, expected to close soon, is the largest corporate acquisition of Ethereum to date and aims to hedge against inflation while diversifying the firm's asset base.

  • Critics argue that the focus on speculative assets like cryptocurrency could divert resources from essential biotech innovations, although the board frames this investment as a long-term growth strategy.

  • This strategic shift may set a precedent for other public companies to adopt similar treasury management strategies, potentially accelerating the maturation of the cryptocurrency market.

  • ETHZilla is also forming a DeFi Council with influential figures from the Ethereum ecosystem to guide its ETH allocation and yield generation strategies.

Summary based on 9 sources


Get a daily email with more Crypto stories

More Stories